Arialys Therapeutics
Clinical trials sponsored by Arialys Therapeutics, explained in plain language.
-
Healthy volunteers help test safety of experimental drug ART5803
Knowledge-focused CompletedThis early-stage study looked at whether a new drug called ART5803 is safe when given together with a common immune treatment (IVIG) in 7 healthy adults. The goal was to check for side effects and how the drug moves through the body. No one in the study had the disease the drug i…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 05:19 UTC
-
First step for new brain inflammation drug: is it safe?
Knowledge-focused CompletedThis early-stage study tested a new drug called ART5803 in 64 healthy adults to see if it is safe and how the body processes it. The drug is being developed for autoimmune encephalitis, a condition where the immune system attacks the brain. Since this was a Phase 1 trial, partici…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC